Quality Care Innovations: Revolutionizing Intensive Care Protocols

Reducing bloodstream infections across the board

A recent study published in the New England Journal of Medicine showed the use of special disinfectant soaps and ointments dramatically reduced the rate of bloodstream infections in ICU patients, specifically MRSA. The study, conducted in 43 hospitals over 18 months, treated approximately 75,000 adult ICU patients nationwide. The results were impressive:

  • Bloodstream infection rates were reduced by 44%
  • MRSA infections, specifically, were reduced by 37%

Establishing new best practices for ICU care

The study found that universal use of these special treatments—antibiotic soaps for the body and nasal ointment for the face (watch the treatment here)— on all ICU patients resulted in even greater reduction of infection rates, slashing them by 50%. Prior protocol would dictate screening patients for the presence of MRSA bacteria before utilizing said treatment. The success of universal treatment protocol is a critical component of the study, the results of which will likely yield changes in ICU treatment in hospitals across America.

HCA, a member organization of the FAH, led this groundbreaking study. HCA Chief Medical Officer Jon Perlin announced the new HCA-developed protocol will be implemented in intensive care practice settings company-wide. All HCA hospitals will be practicing universal application of the disinfectant soap and nasal ointment for all ICU patients to ensure the highest reduction of bloodstream infections.

A Major Success for Hospital Care

Reducing the number of hospital-borne infections is one of the major goals of all hospitals in America. This study makes major progress in continuing that downward trend of hospital infections, and could very well dictate new modes of care beyond the ICU.

MRSA is a serious problem for hospitals across the country. This study provides us with the best defense to keep patients healthy. FAH applauds the efforts of those involved with the study and supports the adoption of this new universal treatment protocol in every hospital.

Not only will such best practices help reduce bloodstream infections in patients, but it will reinforce the commitment of our hospitals to providing the highest quality care.

To Learn More About the MRSA study:

New England Journal of Medicine report
HCA Today Blog & Video Message About the Study

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>